Abstract:Background: Paclitaxel is a natural anticancer drug, which has demonstrated significant activity in clinical trials. However, it has been limited due to poor aqueous solubility. Chitosan can be modified into graft copolymer, which changed into nanoparticles in aqueous solution, and employed as controlled release carriers for drugs. Objective: To study the characterization, in addition, to evaluate in vitro drug release ability of paclitaxel nanoparticles. Design, time and setting: A repeated measurement design was conducted at the Laboratory of North China Coal Medical University from January 2008 to July 2008. Materials: The average molecular weight of 2.0 × 10 5 chitosan with 92% deacetylation degree was produced by Golden-shell Biochemical Co., Ltd. Paclitaxel (lot number: 082329802) was provided by National Institute for the Control of Pharmaceutical and Biological Products. Methods: The potassium diperiodaton-ickelate served as initiator, chitosan-graft-vinyl acetate copolymers were synthesized by free radical graft copolymerization, which could be directly transformed into nanoparticles with hydrophobic core and hydrophilic surface in the water medium. Paclitaxel nanopartioles were prepared via mixture 0.5-5.0 mg paclitaxel with nanoparticles by ultrasonic irradiation technology. Main outcome measures: Particles size, polydispersity index zeta potential was detected by laser particle size analyzer. The morphology of chitosan nanoparticles and paclitaxel nanoparticles was observed by transmission electron microscope. In addition, encapsulation capability, loading content and in vitro drug release of the paclitaxel nanoparticles was analyzed by high-performance liquid chromatography. Results: The mean diameters of chitosan nanoparticles and paclitaxel nanoparticles were 196.2 nm and 320.8 nm, respectively. The nanoparticles possessed a uniform particles size distribution and an obvious positive charge surface, but the Zeta potential had no significant difference (F=0.818, F=3.38, all P > 0.05). The dose of paclitaxel could affect the encapsulation rate, which could up to 93.6% when added the quantity of paclitaxel was 2% of anoparticles. The results of simulate drug release showed that drug release was reach 48.3% in 24 hours at the burst release phase, which up to 75.9% at 175 hours longer in the slower release phase. The encapsulation rate of drug-loaded nanoparticles was stable. Conclusion: The preparation method is reliable and simple. The nanoparticles possessed good physical performance and sustained release character in vitro.

Hyperbranched Poly (Amine-Ester)-poly (Lactide-Co-glycolide) Copolymer and Their Nanoparticles As Paclitaxel Delivery System

Poly(ether-ester Anhydride)-Based Amphiphilic Block Copolymer Nanoparticle As Delivery Devices for Paclitaxel

Poly(Ester Anhydride)/Mpeg Amphiphilic Block Co-Polymer Nanoparticles As Delivery Devices For Paclitaxel

Synthesis, Characterization, And Application Of Amino-Terminated Poly(Ethylene Glycol)-Block-Poly(Epsilon-Caprolactone) Copolymer For Paclitaxel

Synthesis, characterization, and application of amino-terminated poly(ethylene glycol)-block-poly(ε-caprolactone) copolymer for paclitaxel

Hyperbranched Poly (Amine-Ester)-Poly(Epsilon-Caprolactone) Copolymer And Their Nanoparticles As Camptothecin Delivery System

Photo-crosslinked Poly(ethylene Glycol)-B-poly(ϵ-caprolactone) Nanoparticles for Controllable Paclitaxel Release

Methoxy Poly(Ethylene Glycol)-B-Poly(Octadecanoic Anhydride)-B-Methoxy Poly(Ethylene Glycol) Amphiphilic Triblock Copolymer Nanoparticles As Delivery Vehicles for Paclitaxel

Studies on Paclitaxel-Loaded Nanoparticles of Amphiphilic Block Copolymer

Hyperbranched poly (amine-ester)-poly(ε-caprolactone) copolymer and their nanoparticles as camptothecin delivery system

Paclitaxel-Loaded Amphiphilic Copolymer Nanoparticles

Preparation of Amphiphilic Copolymers for Covalent Loading of Paclitaxel for Drug Delivery System

Methoxy poly(ethylene glycol)-b-poly(L-lactic acid) copolymer nanoparticles as delivery vehicles for paclitaxel

Preparation and in Vitro Evaluation of Paclitaxel-Loaded Poly(lactide-co-glycolide) Nanoparticles

Copolymer Nanoparticles Composed of Sulfobetaine and Poly(ε-Caprolactone) As Novel Anticancer Drug Carriers.

Synthesis and characterization of a novel polydepsipeptide contained tri-block copolymer (mPEG-PLLA-PMMD) as self-assembly micelle delivery system for paclitaxel.

Synthesis of Nanoparticles of Star-Shaped Mannitol-Core Pla-Tpgs Copolymer for Delivery of Paclitaxel and Activity of Anti-Prostate Cancer

Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance

[Studies on Paclitaxel-Loaded Methoxy Poly (ethylene Glycol)/poly (L-Lactic Acid) Diblock Copolymer Nanoparticles].

A Self-Assembling Nanoparticle for Paclitaxel Delivery in Ovarian Cancer

Preparation, characterization and drug release property of paclitaxel nanoparticles